Home > Research & Development > Manufacturing Facilities
Manufacturing - Morepen Labs
The company has 3 state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India. The main plant at Parwanoo is Inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally. Morepen has developed a hi-tech Pharma Complex at Morepen Village, Baddi (HP) on 60 acres of land that has various multipurpose pharma facilities for API & finished dosages and a Research Centre. The plant is in process of seeking an endorsement from US-FDA, UK-MCA, South Africa MCC and TGA Australia. Another plant at Parwanoo is exclusively dedicated for manufacturing finished dosage products.
Morepen's Vision is to be a Global pharmaceutical player with strong R&D support and internationally accredited plants in India for cost effective generic products. The focus is primarily on the highly lucrative pharma markets of US, Canada and Europe for hi value finished formulations for which series of ANDA's would be filed. Morepen has resources of international standing and manufacturing facilities adhering to the most stringent standards of quality excellence.
The undiluted commitment to excellence in everything has won Morepen USFDA approval for the manufacturing of Loratadine at its state-of-the-art plant at Masulkhana, Parwanoo. Set amidst pristine pollution-free surroundings where clean air and nature acts as the greatest purifier. The plants themselves are a marvel of proactive, international design made to Global specifications, stringent quality control systems and approvals.